Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02040259 · ClinicalTrials.gov registry record
Trevo® Retriever Registry Post Market Surveillance
A clinical trial, sponsored by Stryker Neurovascular.
- Completed
- Registry status
- 2,008
- Enrollment target
NCT02040259: Completed study, sponsored by Stryker Neurovascular.
NCT02040259 is a clinical trial that has completed, run by Stryker Neurovascular. The registered enrollment target is 2,008 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02040259 has completed, sponsored by Stryker Neurovascular.
- COMPLETED
- Registry status
- 2,008 participants
- Enrollment target
Study Summary
The purpose of the Trevo® Retriever Registry is to collect real world performance data of the Trevo Retriever which is intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke.
Primary Outcome
The primary end point is revascularization based on modified Thrombolysis in Cerebral Infarction score (mTICI). Per protocol, successful revascularization is defined as having a modified TICI score ≥2b at the end of the procedure. Modified TICI Scale (mTICI Scale) Grade 0 - No Perfusion Grade 1 - Penetration with Minimal Perfusion Grade 2 - Partial Perfusion Grade 2a - Only partial filling (\< 50%) of the entire vascular territory is visualized. Grade 2b - Filling of \> 50% all of the expected
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,008 participants |
| Start Date | 2013-11-25 |
| Est. Completion | 2017-12-28 |
What the finished NCT02040259 record still lists
NCT02040259 is an observational study that tracks outcomes without assigning an intervention. Its 2,008 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02040259 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02040259 about?
NCT02040259 is a clinical study titled "Trevo® Retriever Registry Post Market Surveillance". The purpose of the Trevo® Retriever Registry is to collect real world performance data of the Trevo Retriever which is intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke.
What is the current status of trial NCT02040259?
This trial is currently completed. The enrollment target is 2,008 participants. The study started on 2013-11-25. Estimated completion is 2017-12-28.
Who is sponsoring clinical trial NCT02040259?
This trial is sponsored by Stryker Neurovascular, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04100564 · 2,009 participants · NA
LITES Task Order 0005 Prehospital Airway Control Trial (PACT)
- NCT04604509 · 2,010 participants · Phase 4
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI